Mesothelioma, biphasic, malignant
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Cat-Scratch Disease
|
disease |
Infections; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Chloracne
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
38
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Body mass index procedure
|
phenotype |
|
Diagnostic Procedure
|
88
|
252
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Finding of body mass index
|
phenotype |
|
Finding
|
88
|
252
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Hair Color
|
phenotype |
|
Organism Attribute
|
130
|
312
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Sarcomatoid Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
134
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Collecting Duct Carcinoma of the Kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
162
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
trachomatis
|
disease |
|
Disease or Syndrome
|
175
|
7
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Chromophobe Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
185
|
2
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
193
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Papillary Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
223
|
3
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Androgen-Insensitivity Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
247
|
176
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Transitional cell carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
333
|
158
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Adenocarcinoma of pancreas
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
518
|
138
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mesothelioma
|
disease |
Neoplasms
|
Neoplastic Process
|
560
|
4
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
565
|
1138
|
0.100 |
None |
1.000 |
3 |
3
|
2018 |
2019 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Pancreatic Ductal Adenocarcinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
970
|
22
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Liver diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
1019
|
100
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Secondary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1370
|
20
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adult Liver Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1377
|
72
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |